In the News | Friends of Cancer Research

You are here

In the News

January 10, 2020
We went through our analytics: here is what your colleagues in oncology read in 2019.   What are your colleagues reading in The Cancer Letter? Here are the highlights: Robert Peter Gale’s series on... Read more
January 5, 2020
In its continuing efforts to help ensure that patients receive the best treatments in the safest and fastest way possible, the Friends of Cancer Research (FOCR) announced a new pilot project called... Read more
December 30, 2019
A major cancer research advocacy organization wants key House lawmakers to include in their upcoming Cures 2.0 package a policy that would give FDA authority to require generic drug labels be updated... Read more
December 19, 2019
Executive Summary ODAC meetings are usually few and far between – and rarely come with good news for the sponsor. Below are some lessons learned from the bounty (three!) held this week.   The US Food... Read more
December 18, 2019
Armed with a recently awarded five-year $20 million contract from the US Food and Drug Administration to support its work on the PrecisionFDA platform, DNAnexus is working with Deloitte to enhance... Read more
December 18, 2019
In little over seven years, FDA Breakthrough Therapy Designation has been given to almost 200 drugs, resulting in more than 70 treatments being approved approximately two years earlier than would... Read more
December 18, 2019
In recent years, considerable bipartisan Congressional action, leadership from both Democratic and Republican administrations, and broad-based multistakeholder collaborations have focused on... Read more
December 16, 2019
The Senate Committee on Health, Education, Labor and Pensions voted 18-5 in favour of advancing Hahn's nomination to the full Senate last week, after he was put forward for the job by President... Read more
December 12, 2019
Washington, DC – December 12, 2019 – Friends of Cancer Research (Friends) would like to thank the Senate for doing what is right by patients and confirming Dr. Stephen Hahn as FDA commissioner by a... Read more